Telstar Group

Activities: Containment Manufacturing Cleaning Analysis

Trending Articles

  1. Johnson & Johnson to invest $55bn into US manufacturing, R&D and tech The company will build three new advanced pharmaceutical manufacturing facilities on top of its biologics manufacturing site in Wilson, North Carolina, which is currently under...
  2. Maximising efficiency in sample preparation with miVac Sample evaporation and concentration are critical steps in many R&D workflows, but inefficiencies can slow processes and impact results
  3. AstraZeneca puts $2.5bn into Chinese R&D and manufacturing capabilities The pharmaceutical giant will establish its sixth strategic R&D centre in China, as well as novel research and manufacturing agreements in the region
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Forecasting the future of peptide manufacturing: CMC challenges in the GLP-1 era In this article, Torsten Wöhr, Chief Commercial Officer at Bachem, explores the future of peptide CMC manufacturing for GLP-1 therapies, including innovations in sustainable...
  5. Korean certification for portable VOC emissions analyser Signal Group’s portable VOC analyser, the 3010 MiniFID has achieved NIER certification, demonstrating compliance with Article 9 of South Korea’s Environmental Testing and...

Upcoming event

Interphex

1–3 April 2025 | Conference and Exhibition | New York, US See all

Related Content

Manufacturing

Farmak International expands its sterile therapeutic production capacity with new Barcelona facility

The site has R&D, production, logistics, packaging and cold storage space to allow for scalable, end-to-end pharmaceutical manufacturing
Manufacturing

Syntegon acquires Telstar to bolster its aseptic production capabilities

The merger will allow Telstar to grow its business, while Syntegon can boosting its offering of pharmaceutical engineering solutions
Sustainability

Telstar achieves a 10.2% yearly reduction of direct CO2 emissions

The company have endeavoured to improve their sustainability credentials, reducing their direct CO2 emissions by 10.2% in 2023

Telstar to promote new dual mode isolator systems at Pharma Congress 2024

The company will be deploying a compelling portfolio of solutions in the field of process equipment & integrated solutions in isolation technology systems, sterilisation and freeze-drying applications covering the complete phases of a pharmaceutical manufacturing process
Manufacturing

Telstar's robotised station aimed to develop automated loading

The station is designed to conduct loading and unloading tests of their products conveyed towards an autoclave in automated sterilisation processes
Digital

Telstar's GMP digitisation solutions and process automation

The company's new applications are designed to facilitate the improvement of productive efficiency in the pharmaceutical industry,
Manufacturing

Telstar's international alliance strengthens EtO sterilisation development

The company looks to integrate Picarro's monitoring technology into its sterilisation plants
Subscribe now